| [1] |
Siegel RL, Wagle NS, Cercek A, et al.Colorectal cancer statistics, 2023[J]. CA Cancer J Clin，2023, 73(3): 233-254.
|
| [2] |
中华人民共和国国家卫生健康委员会医政医管局，中华医学会肿瘤学分会．中国结直肠癌诊疗规范(2020年版)[J]．中国实用外科杂志，2020，40(6)：601-625.
|
| [3] |
中国医师协会内镜医师分会消化内镜专业委员会，中国抗癌协会肿瘤内镜学专业委员会．中国消化内镜诊疗相关肠道准备指南(2019，上海)[J]．中华消化内镜杂志，2019，36(7)：457-469.
|
| [4] |
Gimeno-García AZ, Baute JL, Hernandez G, et al.Risk factors for inadequate bowel preparation：a validated predictive score[J]．Endoscopy, 2017，49(6): 536-543.
|
| [5] |
Johnson DA, Barkun AN, Cohen LB, et al.Optimizing adequacy of bowel cleansing for colonoscopy：recommendations from the US multi-society task force on colorectal cancer[J]．ACG，2014，109(10): 1528-1545.
|
| [6] |
黄涵，蔡妍，陈卫建，等．慢性便秘的结肠镜检查前肠道准备口服药物研究进展[J]．新医学，2024，55(4)：255-259.
|
| [7] |
廖晓玲，彭薇淇，杨阮阮，等．利那洛肽联合复方聚乙二醇电解质散应用于慢性便秘患者肠道准备的效果评价[J]．现代消化及介入诊疗，2025，30(6)：673-677.
|
| [8] |
YooOO IK, Lee EE JS, ChunHUN HJ, et al.A randomized, prospective trial on efficacy and tolerability of low-volume bowel preparation methods for colonoscopy[J]．Dig Liver Dis，2015，47(2): 131-137.
|
| [9] |
Hassan C, East J, Radaelli F, et al.Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline- update 2019[J]．Endoscopy，2019，51(8)：775-794.
|
| [10] |
廖锦文，申文莉，吴兰，等．利那洛肽联合西甲硅油与复方聚乙二醇电解质散对便秘患者肠道清洁效果的影响[J]．中国内镜杂志，2025，31 (6)：44-53.
|
| [11] |
Jaobson BC, Anderson JC, Burke CA, et al.Optimizing bowel preparation quality for colonoscopy：consensus recommendations by the US Multi-Society Task Force on Colorectal Cancer[J]．Gastrointest Endosc，2025，101(4): 702-32.
|
| [12] |
Taylor DCA, Abel JL, Doshi JA, et al.The impact of stool consistency on bowel movement satisfaction in patients with IBS-C or CIC treated with linaclotide or other medications：real-world evidence from the CONTOR study[J]．J Clin Gastroenterol，2019，53(10)：737-743.
|
| [13] |
Linaclotide.Drugs and Lactation Database(LactMed(R))[M]. Bethesda (MD).2006.
|
| [14] |
Camilleri M, Buéno L, Andresen V, et al.Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders[J]．Gastroenterology，2016，150(6)：1319-1331.e20.
|
| [15] |
Liu W, Shu L, Zhou X, et al.Evaluation of the efficacy of polyethylene glycol in combination with different doses of linaclotide in a fractionated bowel preparation for colonoscopy：a prospective randomized controlled study[J]．Int J Color Dis，2024，39(1)：143.
|
| [16] |
黄欣，杨茹洁，秦峰，等．硫酸镁钠钾口服液在内镜肠道清洁准备中的效果[J]．药学实践与服务，2026，44(2)：85-87，102.
|
| [17] |
Wenqi S, Bei Z, Yunrong W, et al.Lactulose vs polyethylene glycol for bowel preparation：a single-center，prospective，randomized controlled study based on BMI[J]．Clin Trans Gastroenterol，2024，15(1): e00652.
|
| [18] |
廖锦文，申文莉，吴兰，等．利那洛肽联合西甲硅油与复方聚乙二醇电解质散对便秘患者肠道清洁效果的影响[J]．中国内镜杂志，2025, 31(6)：44-53.
|
| [19] |
中华医学会消化病学分会胃肠动力学组，中华医学会消化病学分会功能性胃肠病协作组. 中国慢性便秘专家共识意见(2019，广州)[J]. 中华消化杂志，2019，39(9)：577-598.
|
| [20] |
郭宗儒．口服治疗慢性便秘的肽类药物利那洛肽和普卡那肽[J]. 药学学报，2021，56(4)：1197-1200.
|
| [21] |
Chang L, Chey WD, Imdad A, et al.American Gastroenterological Association-American College of Gastroenterology clinical practice guideline：pharmacological management of chronic idiopathic constipation[J]．Gastroenterology，2023，164(7)：1086-1106.
|
| [22] |
Niedermaier T, Amitay EL, Gies A, et al.Impact of inadequate bowel cleansing on colonoscopic findings in routine screening practice[J]．Clin Trans Gastroenterol，2020，11(4)：e00169.
|
| [23] |
Milosavljevic T, Popovic DD, Mijac DD, et al.Chronic constipation: gastroenterohepatologist′s approach[J]．Dig Dis，2022，40(2)：175-180.
|
| [24] |
张建军，王海鹏，董广峰，等．复方聚乙二醇电解质散联合利那洛肽改善老年便秘患者结肠镜前肠道准备效果的随机对照研究[J]．实用医学杂志，2025，41(19)：2967-2971.
|
| [25] |
Yoshihara T, Kessoku T, Takatsu T, et al.Efficacy and safety of linaclotide in treatment-resistant chronic constipation: a multicenter，open-label study[J]．Neurogastroenterol Motility，2024，36(12): e14938.
|